Bank of America’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-65,031
| Closed | -$729K | – | 6513 |
|
|
2017
Q3 | $729K | Sell |
65,031
-9,262
| -12% | -$104K | ﹤0.01% | 4023 |
|
|
2017
Q2 | $817K | Sell |
74,293
-7,984
| -10% | -$87.8K | ﹤0.01% | 3921 |
|
|
2017
Q1 | $806K | Buy |
82,277
+39,508
| +92% | +$387K | ﹤0.01% | 3939 |
|
|
2016
Q4 | $462K | Buy |
42,769
+36,346
| +566% | +$393K | ﹤0.01% | 4148 |
|
|
2016
Q3 | $66K | Sell |
6,423
-2,025
| -24% | -$20.8K | ﹤0.01% | 4865 |
|
|
2016
Q2 | $110K | Sell |
8,448
-5,789
| -41% | -$75.4K | ﹤0.01% | 4700 |
|
|
2016
Q1 | $157K | Sell |
14,237
-1,006
| -7% | -$11.1K | ﹤0.01% | 4491 |
|
|
2015
Q4 | $140K | Sell |
15,243
-17,015
| -53% | -$156K | ﹤0.01% | 4637 |
|
|
2015
Q3 | $224K | Sell |
32,258
-6,905
| -18% | -$47.9K | ﹤0.01% | 4332 |
|
|
2015
Q2 | $385K | Buy |
39,163
+7,284
| +23% | +$71.6K | ﹤0.01% | 3978 |
|
|
2015
Q1 | $283K | Sell |
31,879
-2,641
| -8% | -$23.4K | ﹤0.01% | 3820 |
|
|
2014
Q4 | $303K | Sell |
34,520
-8,063
| -19% | -$70.8K | ﹤0.01% | 3911 |
|
|
2014
Q3 | $293K | Sell |
42,583
-120,919
| -74% | -$832K | ﹤0.01% | 3828 |
|
|
2014
Q2 | $861K | Buy |
163,502
+19,900
| +14% | +$105K | ﹤0.01% | 3142 |
|
|
2014
Q1 | $653K | Buy |
143,602
+125
| +0.1% | +$568 | ﹤0.01% | 3352 |
|
|
2013
Q4 | $723K | Sell |
143,477
-6,501
| -4% | -$32.8K | ﹤0.01% | 3382 |
|
|
2013
Q3 | $760K | Sell |
149,978
-22,239
| -13% | -$113K | ﹤0.01% | 3192 |
|
|
2013
Q2 | $854K | Buy |
+172,217
| New | +$854K | ﹤0.01% | 3286 |
|